Rene Bernards
Science Park
Amsterdam, NH, Netherlands
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 205 publications
Turning CDK4/6 inhibitors against the dark side of senescence.
Journal: Nature aging
Published: August 20, 2026
Exploiting immunogenic cell death to promote antitumor immunity.
Journal: Trends in immunology
Published: February 02, 2026
CLIM-TIME links genetic cancer drivers to immune landscapes.
Journal: Cell
Published: January 09, 2026
European cancer research requires renewed urgency.
Journal: Nature cancer
Published: December 10, 2025
The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 20, 2025
XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma.
Journal: Cell chemical biology
Published: October 03, 2025
CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 24, 2025
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.
Journal: Cancer cell
Published: August 21, 2025
CRISPR knockout screens reveal JUN as the master mediator of resistance to MAPK inhibition in KRAS-mutant pancreatic cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 15, 2025
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 30, 2025
Last Updated: 09/26/2026